264 related articles for article (PubMed ID: 10871932)
1. Clinical significance of skin biopsies in the diagnosis and management of graft-vs-host disease in early postallogeneic bone marrow transplantation.
Zhou Y; Barnett MJ; Rivers JK
Arch Dermatol; 2000 Jun; 136(6):717-21. PubMed ID: 10871932
[TBL] [Abstract][Full Text] [Related]
2. Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease.
Kohler S; Hendrickson MR; Chao NJ; Smoller BR
Am J Surg Pathol; 1997 Sep; 21(9):988-96. PubMed ID: 9298874
[TBL] [Abstract][Full Text] [Related]
3. Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow.
Heldal D; Brinch L; Evensen SA; Tjønnfjord GE; Aamodt G; Elgjo K; Sviland L
Bone Marrow Transplant; 2004 Aug; 34(4):345-50. PubMed ID: 15170163
[TBL] [Abstract][Full Text] [Related]
4. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease.
Marra DE; McKee PH; Nghiem P
J Am Acad Dermatol; 2004 Oct; 51(4):543-6. PubMed ID: 15389188
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of gastrointestinal graft-versus-host disease--is rectal biopsy enough?
Nydegger A; Catto-Smith AG; Tiedemann K; Hardikar W
Pediatr Blood Cancer; 2007 May; 48(5):561-6. PubMed ID: 16862539
[TBL] [Abstract][Full Text] [Related]
7. The role of skin biopsies in bone marrow transplant recipients.
Hepburn NC; McLaren KM; Turner ML; Beveridge GW
Q J Med; 1993 Nov; 86(11):715-7. PubMed ID: 8265771
[TBL] [Abstract][Full Text] [Related]
8. Histological features of skin and rectal biopsy specimens after autologous and allogeneic bone marrow transplantation.
Sviland L; Pearson AD; Eastham EJ; Hamilton PJ; Proctor SJ; Malcolm AJ
J Clin Pathol; 1988 Feb; 41(2):148-54. PubMed ID: 3280605
[TBL] [Abstract][Full Text] [Related]
9. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L
Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394
[TBL] [Abstract][Full Text] [Related]
10. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
[TBL] [Abstract][Full Text] [Related]
11. Lichen planus-like histopathologic characteristics in the cutaneous graft-vs-host reaction. Prognostic significance independent of time course after allogeneic bone marrow transplantation.
Horn TD; Zahurak ML; Atkins D; Solomon AR; Vogelsang GB
Arch Dermatol; 1997 Aug; 133(8):961-5. PubMed ID: 9267240
[TBL] [Abstract][Full Text] [Related]
12. Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis.
Firoz BF; Lee SJ; Nghiem P; Qureshi AA
Arch Dermatol; 2006 Feb; 142(2):175-82. PubMed ID: 16490845
[TBL] [Abstract][Full Text] [Related]
13. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
[TBL] [Abstract][Full Text] [Related]
14. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group.
Appleton AL; Sviland L; Peiris JS; Taylor CE; Wilkes J; Green MA; Pearson AD; Kelly PJ; Malcolm AJ; Proctor SJ
Bone Marrow Transplant; 1995 Dec; 16(6):777-82. PubMed ID: 8750269
[TBL] [Abstract][Full Text] [Related]
15. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
Toren A; Barak V; Novick D; Nagler A
Cytokines Cell Mol Ther; 1997 Sep; 3(3):153-8. PubMed ID: 9426973
[TBL] [Abstract][Full Text] [Related]
16. Colon biopsies for evaluation of acute graft-versus-host disease (A-GVHD) in allogeneic bone marrow transplant patients.
Shidham VB; Chang CC; Shidham G; Ghazala F; Lindholm PF; Kampalath B; George V; Komorowski R
BMC Gastroenterol; 2003 Mar; 3():5. PubMed ID: 12697049
[TBL] [Abstract][Full Text] [Related]
17. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
18. Clinical, laboratory, and histopathologic indicators of the development of progressive acute graft-versus-host disease.
Darmstadt GL; Donnenberg AD; Vogelsang GB; Farmer ER; Horn TD
J Invest Dermatol; 1992 Oct; 99(4):397-402. PubMed ID: 1401996
[TBL] [Abstract][Full Text] [Related]
19. Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation.
van der Straaten HM; Fijnheer R; Dekker AW; Nieuwenhuis HK; Verdonck LF
Br J Haematol; 2001 Jul; 114(1):31-5. PubMed ID: 11472341
[TBL] [Abstract][Full Text] [Related]
20. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
